Optimized processing for pathogen inactivation of double-dose buffy-coat platelet concentrates: maintained in vitro quality over 7-day storage

Vox Sanguinis

Volumn 113, Issue 7, 2018, Pages 611-621

  Ohlsson, S ^a   Diedrich, B ^a,b   Uhlin, M ^a,b   Sandgren, P ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

buffy coat; pathogen reduction; Platelets

Indexed keywords

AMOTOSALEN; BIOLOGICAL RESPONSE MODIFIER; CD40 LIGAND; DUAL SPECIFICITY PHOSPHATASE 2; GLYCOPROTEIN IB ALPHA; INTEGRIN; LACTIC ACID; PADGEM PROTEIN; PLATELET DERIVED GROWTH FACTOR; PLATELET ENDOTHELIAL CELL ADHESION MOLECULE 1; THROMBOCYTE CONCENTRATE; FUROCOUMARIN DERIVATIVE;

ANAEROBIC GLYCOLYSIS; ARTICLE; BLOOD BUFFY COAT; CARBON DIOXIDE TENSION; CONTROLLED STUDY; DOUBLE DOSE PROCESSING; DOWN REGULATION; GLUCOSE INTAKE; IN VITRO STUDY; MEAN PLATELET VOLUME; MITOCHONDRIAL MEMBRANE POTENTIAL; OXYGEN TENSION; PLATELET COUNT; PRIORITY JOURNAL; PROCESS OPTIMIZATION; THROMBOCYTE FUNCTION; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION; ULTRAVIOLET A RADIATION; BLOOD STORAGE; DRUG EFFECT; HUMAN; PROCEDURES; RADIATION RESPONSE; STANDARDS; THROMBOCYTE; ULTRAVIOLET RADIATION;

BLOOD BUFFY COAT; BLOOD PLATELETS; BLOOD PRESERVATION; FUROCOUMARINS; HUMANS; ULTRAVIOLET RAYS;

EID: 85052784459     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12696     Document Type: Article

References (17)

1. Knutson F, Alfonso R, Dupuis K, et al.: CF Högman. Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function. Vox Sang 2000; 78:209–216
2. Knutson F, Osselaer J, Pierelli L, et al.: A prospective, active haemovigilance study with combined cohort analysis of 19 175 transfusions of platelet components prepared with amotosalen-UVA photochemical treatment. Vox Sang 2015; 109:343–352
3. Irsch J, Lin L: Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood System. Transfus Med Hemother 2011; 38:19–31
4. Sandgren P, Diedrich B: Pathogen inactivation of double-dose buffy-coat platelet concentrates photochemically treated with amotosalen and UVA light: preservation of in vitro function. Vox Sang 2015; 108:340–349
5. Gulliksson H, AuBuchon JP, Vesterinen M, et al.: Storage of platelets in additive solutions: a pilot in vitro study of the effects of potassium and magnesium. Vox Sang 2002; 82:131–136
6. Sandgren P, Callaert M, Shanwell A, et al.: Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study. Transfusion 2008; 48:688–696
7. Sandgren P, Meinke S, Eckert E, et al.: Random aggregates in newly produced platelet units are associated with platelet activation and release of the immunomodulatory factors sCD40L and RANTES. Transfusion 2014; 54:602–612
8. Sandgren P, Ronnmark J, Axelsson J: In vitro affinity reduction of biologic response modifiers from production buffy coat platelets exposed to recombinant protein receptors. Transfusion 2015; 55:1919–1926
9. EDQM Guidelines; Guide to the preparation, use quality assurance of blood components, Recommendation No. R(95) 15, 18th edn, 2015
10. Gulliksson H: Defining the optimal storage conditions for the long-term storage of platelets. Transfus Med Rev 2003; 17:209–215
11. Bergsten MB, Norda RN, Hardarson BH, et al.: Adequate leukodepletion of platelet concentrates from pools of 7 or 8 buffy-coats for photochemical pathogen inactivation treatment of double transfusion doses. Vox Sang 2015; 109(Suppl. 1):1–379
12. Holme S, Heaton WA, Courtright M: Platelet storage lesion in second-generation containers: correlation with platelet ATP levels. Vox Sang 1987; 53:214–220
13. Kilkson H, Holme S, Murphy S: Platelet metabolism during storage of platelet concentrates at 22 degrees C. Blood 1984; 64:406–414
14. Gulliksson H, Sandgren P, Sjodin A, et al.: Storage of platelets: effects associated with high platelet content in platelet storage containers. Blood Transfus 2012; 10:205–212
15. Sandgren P, Stjepanovic A: High-yield platelet units revealed immediate pH decline and delayed mitochondrial dysfunction during storage in 100% plasma as compared with storage in SSP+. Vox Sang 2012; 103:55–63
16. Cognasse F, Boussoulade F, Chavarin P, et al.: Release of potential immunomodulatory factors during platelet storage. Transfusion 2006; 46:1184–1189
17. Cognasse F, Osselaer JC, Payrat JM, et al.: Release of immune modulation factors from platelet concentrates during storage after photochemical pathogen inactivation treatment. Transfusion 2008; 48:809–813